Artemis Medicare Services per share figures

Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
₹7.25₹6.56₹5.37₹3.62₹2.89
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
₹7.25₹6.56₹5.31₹3.53₹2.79
₹59.04₹59.04₹60.88₹33.00₹30.06
₹72.64₹68.30₹68.09₹64.67₹54.98
—₹8.33₹10.58₹8.01₹9.48
₹1.71₹1.71₹3.81₹2.67−₹1.44
—₹0.39₹0.43₹0.45₹0.00
15.815.813.813.613.4
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

ARTEMISMED₹278.60

Artemis Medicare Services Limited

· Pharma & Health
₹ CrorePeersINDRAMEDCOSHALBYGKSLGPTHEALTHLOTUSEYEDRAGARWQKMCSHILKOVAIMcap ₹4,410 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
₹ per share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Basic EPS2.893.625.376.567.25
Diluted EPS2.793.535.316.567.25
Book Value per Share30.0633.0060.8859.0459.04
Revenue per Share54.9864.6768.0968.3072.64
Cash Flow per Share9.488.0110.588.33—
Free Cash Flow per Share-1.442.673.811.711.71
Dividends per Share0.000.450.430.39—
Shares Outstanding (cr)13.413.613.815.815.8
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.